6086-24-4

Usage

Uses

Used in Chemical Research:
BENZOFUROXAN-5-CARBOXYLIC ACID is used as a research compound for its unique chemical properties, contributing to the advancement of scientific knowledge in the field of chemistry.
Used in Synthesis:
BENZOFUROXAN-5-CARBOXYLIC ACID is used as a synthetic intermediate in the production of various chemical compounds, facilitating the creation of new materials and substances.

InChI:InChI=1/C16H24N4O2S3/c21-13(19-7-3-1-4-8-19)11-23-15-17-16(25-18-15)24-12-14(22)20-9-5-2-6-10-20/h1-12H2

Upstream product

• 96-99-1 4-chloro-3-nitrobenzoate 
• 1588-83-6 4-amino-3-nitrobenzoic acid 
• 39608-47-4 3-chloro-4-nitrobenzoic acid 
• 54974-60-6 4-azido-3-nitro-benzoic acid 

Downstream Products

• 36389-06-7 5-acetylbenzofuroxan 
• 6086-26-6 1-oxy-benzo[1,2,5]oxadiazole-5-carbonyl chloride 
• 19155-88-5 benzo[c][1,2,5]oxadiazole-5-carboxylic acid 
• 54286-62-3 benzo[c][1,2,5]oxadiazole-5-carbonitrile 
• 126147-86-2 benzofurazan-5-carbonyl chloride 
• 1061063-13-5 N-[1-(3,5-dimethylphenyl)-1H-4,5,6,7-tetrahydroindazol-4-yl]-2,1,3-benzoxadiazole-5-carboxamide 1-oxide 

Relevant academic research and scientific papers

Synthesis and biological evaluation of novel histone deacetylases inhibitors with nitric oxide releasing activity

A novel series of histone deacetylases inhibitors (HDACIs) containing benzofuroxan pharmacophore as nitric oxide (NO) donor were designed based on the combination principle and 'multifunctional drugs' theory. As a novel study on embedding NO donor into th

BICYCLIC AMIDES FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES

This invention relates to compounds, pharmaceutical compositions and methods for use in the prevention and treatment of cerebral insufficiency, including enhancement of receptor functioning in synapses in brain networks responsible for basic and higher order behaviors. These brain networks, which are involved in regulation of breathing, and cognitive abilities related to memory impairment, such as is observed in a variety of dementias, in imbalances in neuronal activity between different brain regions, as is suggested in disorders such as Parkinson's disease, schizophrenia, respiratory depression, sleep apneas, attention deficit hyperactivity disorder and affective or mood disorders, and in disorders wherein a deficiency in neurotrophic factors is implicated, as well as in disorders of respiration such as overdose of an alcohol, an opiate, an opioid, a barbiturate, an anesthetic, or a nerve toxin, or where the respiratory depression results form a medical condition such as central sleep apnea, stroke-induced central sleep apnea, obstructive sleep apnea, congenital hypoventilation syndrome, obesity hypoventilation syndrome, sudden infant death syndrome, Rett syndrome, spinal cord injury, traumatic brain injury, Cheney-Stokes respiration, Ondines curse, Prader-Willi's syndrome and drowning, hi a particular aspect, the invention relates to bicyclic amide compounds useful for treatment of such conditions, and methods of using these compounds for such treatment.

Synthesis of carboxyimidamide-substituted benzo[c][1,2,5]oxadiazoles and their analogs, and evaluation of biological activity against Leishmania donovani

A facile synthesis route to carboxyimidamide-substituted benzoxadiazoles and related derivatives was developed. A total of 25 derivatives were synthesized. They were evaluated for antileishmanial activity by inhibition of Leishmania donovani axenic amastigote growth using a fluorescent viability microplate assay. The most promising derivative (14) demonstrated an antileishmanial EC50 of 4.0 μM, and it also showed activity in infected macrophages (EC50 5.92 μM) without signs of cytotoxicity.

Straightforward one-pot synthesis of benzofuroxans from o-halonitrobenzenes in ionic liquids

Treatment of o-halonitrobenzenes with sodium azide in a [empyrr][BF4]/Bu4NBr/H2O system gives benzofuroxans in high yields, with the recovery and reuse of the ionic liquid for at least ten times.